BioNTech Historical Cash Flow

BNTX Stock  USD 97.39  0.34  0.35%   
Analysis of BioNTech cash flow over time is an excellent tool to project BioNTech SE future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Inventory of 78.2 M or Change Receivables of 0.0 as it is a great indicator of BioNTech ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining BioNTech SE latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioNTech SE is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About BioNTech Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in BioNTech balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which BioNTech's non-liquid assets can be easily converted into cash.

BioNTech Cash Flow Chart

BioNTech reported Sale Purchase Of Stock of (738.5 Million) in 2024. Change To Inventory is likely to rise to about 78.2 M in 2025, despite the fact that Investments are likely to grow to (2 B).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by BioNTech SE to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of BioNTech operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from BioNTech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into BioNTech SE current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
BioNTech reported Sale Purchase Of Stock of (738.5 Million) in 2024. Change To Inventory is likely to rise to about 78.2 M in 2025, despite the fact that Investments are likely to grow to (2 B).

BioNTech cash flow statement Correlations

-0.240.02-0.02-0.190.170.940.350.27-0.350.280.94-0.630.33-0.05-0.06-0.13
-0.240.320.44-0.34-0.21-0.41-0.85-0.610.31-0.89-0.360.05-0.63-0.6-0.60.61
0.020.32-0.090.410.860.2-0.3-0.09-0.770.060.20.650.430.150.16-0.03
-0.020.44-0.09-0.57-0.36-0.05-0.58-0.610.47-0.590.01-0.4-0.59-0.75-0.70.96
-0.19-0.340.41-0.570.57-0.050.530.72-0.640.67-0.120.680.80.90.9-0.65
0.17-0.210.86-0.360.570.430.140.21-0.960.530.410.640.770.460.46-0.38
0.94-0.410.2-0.05-0.050.430.390.27-0.570.471.0-0.410.530.070.07-0.19
0.35-0.85-0.3-0.580.530.140.390.92-0.350.870.31-0.090.70.80.79-0.77
0.27-0.61-0.09-0.610.720.210.270.92-0.440.760.180.070.740.890.89-0.78
-0.350.31-0.770.47-0.64-0.96-0.57-0.35-0.44-0.64-0.53-0.5-0.88-0.59-0.590.53
0.28-0.890.06-0.590.670.530.470.870.76-0.640.40.210.910.810.81-0.75
0.94-0.360.20.01-0.120.411.00.310.18-0.530.4-0.440.46-0.02-0.02-0.11
-0.630.050.65-0.40.680.64-0.41-0.090.07-0.50.21-0.440.390.50.5-0.31
0.33-0.630.43-0.590.80.770.530.70.74-0.880.910.460.390.820.82-0.72
-0.05-0.60.15-0.750.90.460.070.80.89-0.590.81-0.020.50.821.0-0.86
-0.06-0.60.16-0.70.90.460.070.790.89-0.590.81-0.020.50.821.0-0.82
-0.130.61-0.030.96-0.65-0.38-0.19-0.77-0.780.53-0.75-0.11-0.31-0.72-0.86-0.82
Click cells to compare fundamentals

BioNTech Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.